Abbott Earned $1.32 Per Share for Q4

This morning, Abbott Laboratories (ABT) reported Q4 earnings of $1.32 per share. That beat expectations of $1.21. Sales rose 7.2% to $11.5 billion. Of that, Covid testing made up $2.3 billion.

For the year, Abbott earned $5.21 per share. Abbott has distributed more than 1.4 billion Covid tests since the start of the pandemic.

“2021 was an outstanding year for Abbott,” said Robert B. Ford, chairman and chief executive officer, Abbott. “We achieved more than 40 percent EPS growth, exceeding the baseline EPS guidance we set at the beginning of last year and, importantly, continued to advance our new product pipeline across the portfolio.”

For this year, Abbott expects earnings of at least $4.70 per share. That’s based on test sales of $2.5 billion. Wall Street had been expecting $4.78 per share.

Posted by on January 26th, 2022 at 9:09 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.